Lantheus Holdings (LNTH) Cash from Investing Activities Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) Cash from Investing Activities Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 8.16% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 26.15% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 51.85% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 75.05% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 33.33% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -129.09% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -2.94% |
| 10 | Lantheus Holdings | 7.04 Bn | 6.54 Bn | 230.92 Mn | 37.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.22% |
| Dec 31, 2025 | 64.84% |
| Sep 30, 2025 | -274.34% |
| Jun 30, 2025 | -276.87% |
| Mar 31, 2025 | -257.89% |
| Dec 31, 2024 | -13.26% |
| Sep 30, 2024 | -203.72% |
| Jun 30, 2024 | -157.00% |
| Mar 31, 2024 | -115.50% |
| Dec 31, 2023 | -47.19% |
| Sep 30, 2023 | 189.55% |
| Jun 30, 2023 | -80.70% |
| Mar 31, 2023 | -154.57% |
| Dec 31, 2022 | -282.22% |
| Sep 30, 2022 | -22.22% |
| Jun 30, 2022 | -8.14% |
| Mar 31, 2022 | 49.12% |
| Dec 31, 2021 | 14.87% |
| Sep 30, 2021 | 21.51% |
| Jun 30, 2021 | 22.13% |